Amalgamated Bank
RPRX icon

Amalgamated Bank’s Royalty Pharma RPRX Stock Holding History

Amalgamated Bank’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.17M Sell
20,106
-186
-0.9% -$11K 0.01% 1003
2026
Q2 		$1.14M Sell
20,292
-16,477
-45% -$858K 0.01% 1050
2026
Q1 		$1.76M Buy
36,769
+15,062
+69% +$660K 0.01% 862
2025
Q4 		$839K Buy
21,707
+386
+2% +$14.7K 0.01% 1141
2025
Q3 		$752K Sell
21,321
-979
-4% -$35.4K 0.01% 1166
2025
Q2 		$803K Buy
22,300
+1,877
+9% +$62.2K 0.01% 1124
2025
Q1 		$636K Buy
20,423
+866
+4% +$27.4K 0.01% 1168
2024
Q4 		$499K Sell
19,557
-912
-4% -$24.2K ﹤0.01% 1298
2024
Q3 		$579K Sell
20,469
-48,057
-70% -$1.33M ﹤0.01% 1249
2024
Q2 		$1.81M Buy
68,526
+47,632
+228% +$1.32M 0.02% 866
2024
Q1 		$635K Sell
20,894
-11,183
-35% -$330K 0.01% 1222
2023
Q4 		$901K Sell
32,077
-3,688
-10% -$101K 0.01% 1214
2023
Q3 		$971K Sell
35,765
-330
-0.9% -$9.8K 0.01% 1129
2023
Q2 		$1.11M Sell
36,095
-3,463
-9% -$117K 0.01% 1096
2023
Q1 		$1.42M Buy
39,558
+2,251
+6% +$83.5K 0.01% 990
2022
Q4 		$1.47M Buy
37,307
+561
+2% +$23.4K 0.01% 1007
2022
Q3 		$1.48M Sell
36,746
-2,506
-6% -$107K 0.01% 960
2022
Q2 		$1.65M Buy
39,252
+4,399
+13% +$180K 0.02% 939
2022
Q1 		$1.36M Buy
+34,853
New +$1.37M 0.01% 1085

Other funds holding RPRX

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Hosking Partners
Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return
Kepler Cheuvreux
Kepler Cheuvreux Nyon $1.65B AUM 36.86% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Kirr Marbach & Co
Kirr Marbach & Co Columbus, Indiana $530M AUM 14.37% 1-Year Est. Return
Triasima Portfolio Management
Triasima Portfolio Management Montreal, Quebec, Canada $758M AUM 48.16% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

Amalgamated Bank's RPRX Position: Q3 2026 in Review

Amalgamated Bank reduced its Royalty Pharma (RPRX) stake by 0.92% in Q3 2026, selling an estimated $11K and leaving 20,106 shares worth $1.17M. The position accounts for 0.01% of the portfolio, ranked #1003.

Amalgamated Bank first reported a position in RPRX in Q1 2022 and has held it in 19 quarters since. The position peaked at $1.81M in Q2 2024. 129 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Amalgamated Bank held 20,106 shares of Royalty Pharma worth $1.17M as of Q3 2026.
  • Amalgamated Bank sold 186 Royalty Pharma shares in Q3 2026, an estimated $11K.
  • Royalty Pharma made up 0.01% of Amalgamated Bank's portfolio in Q3 2026, its #1003 holding.
  • Amalgamated Bank first reported a position in Royalty Pharma in Q1 2022 and has held it in 19 quarters since.
  • Amalgamated Bank's Royalty Pharma position peaked at $1.81M in Q2 2024.
  • 129 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Amalgamated Bank's 13F filing for Q3 2026, filed 23 Oct 2026.